UK markets close in 3 hours 47 minutes

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.39-1.02 (-3.86%)
At close: 04:00PM EDT
25.89 +0.50 (+1.97%)
After hours: 04:37PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/03/2024
31/03/2023
31/03/2022
31/03/2021
Assets
Current assets
Cash
Cash and cash equivalents
635,365
376,532
493,817
400,146
Total cash
635,365
376,532
493,817
400,146
Net receivables
5,337
700
12,229
596
Other current assets
24,902
26,916
6,253
7,716
Total current assets
665,770
404,333
512,931
409,006
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
595
1,505
2,633
3,483
Net property, plant and equipment
595
1,505
2,633
3,483
Total non-current assets
595
1,505
2,633
3,483
Total assets
666,365
405,838
515,564
412,489
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
7,155
1,353
18,629
2,432
Accrued liabilities
26,556
32,891
20,119
12,022
Total current liabilities
48,608
43,297
44,520
18,771
Non-current liabilities
Total non-current liabilities
0
47
1,219
2,238
Total liabilities
48,608
43,344
45,739
21,009
Stockholders' equity
Common stock
14
13
12
10
Retained earnings
-825,683
-566,347
-355,387
-198,657
Accumulated other comprehensive income
1,908
852
404
-298
Total stockholders' equity
617,757
362,494
469,825
391,480
Total liabilities and stockholders' equity
666,365
405,838
515,564
412,489